Kewaunee Scientific Corporation KEQU
$ 43.93
2.71%
Quarterly report 2024-Q2
added 09-13-2024
Kewaunee Scientific Corporation Balance Sheet 2011-2024 | KEQU
Annual Balance Sheet Kewaunee Scientific Corporation
2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-20.9 M | -5.96 M | -3.77 M | 9.55 M | 130 K | -3.4 M | -5.57 M | 2.37 M | 6.1 M | 1.52 M | 4.65 M | 4.3 M | 8.05 M | |
Long Term Debt |
235 K | 148 K | - | 91 K | - | 97 K | 1.26 M | 2.43 M | 3.35 M | 3.77 M | 4.19 M | 3.27 M | 3.47 M | 3.67 M |
Long Term Debt Current |
2.12 M | 1.97 M | 1.32 M | 1.35 M | 1.28 M | 1.17 M | 1.17 M | 918 K | 421 K | 421 K | 421 K | 200 K | 200 K | - |
Total Non Current Liabilities |
- | - | - | - | 18.2 M | 6.79 M | 9.28 M | 10.7 M | 12.9 M | 13.2 M | 12.3 M | 12.9 M | 12.2 M | 9.78 M |
Total Current Liabilities |
40.8 M | 40.1 M | 42.3 M | 34.2 M | 27.1 M | 32.7 M | 27.6 M | 26.9 M | 21 M | 21.1 M | 16.2 M | 22.1 M | 20.2 M | - |
Total Liabilities |
78.6 M | 80.4 M | 82.6 M | 47.9 M | 45.2 M | 39.5 M | 36.8 M | 37.7 M | 33.9 M | 34.3 M | 28.5 M | 35 M | 32.5 M | 30 M |
Deferred Revenue |
4.37 M | 4.1 M | 3.53 M | 3.12 M | 2.51 M | 1.6 M | 1.88 M | 5.81 M | 785 K | 216 K | 137 K | 488 K | 1.36 M | 1.11 M |
Retained Earnings |
47.5 M | 28.8 M | 28 M | 34.1 M | 37.8 M | 43.6 M | 43.2 M | 39.8 M | 36.8 M | 34.4 M | 32.1 M | 31.2 M | 29.2 M | 29.2 M |
Total Assets |
135 M | 119 M | 119 M | 89.4 M | 83.9 M | 87.2 M | 84.4 M | 80.9 M | 72.4 M | 69.5 M | 62.7 M | 68.7 M | 64.1 M | 63.1 M |
Cash and Cash Equivalents |
23.3 M | 8.08 M | 4.43 M | 5.21 M | 4.36 M | 10.6 M | 9.72 M | 12.5 M | 5.22 M | 3.04 M | 6.25 M | 5.81 M | 6.19 M | 2.4 M |
Book Value |
56.2 M | 38.5 M | 36.2 M | 41.5 M | 38.7 M | 47.7 M | 47.5 M | 43.3 M | 38.6 M | 35.2 M | 34.2 M | 33.7 M | 31.7 M | 33 M |
Total Shareholders Equity |
54.8 M | 37.4 M | 35.7 M | 41.2 M | 38.4 M | 47.1 M | 47.7 M | 42.9 M | 38.2 M | 34.9 M | 34 M | 31.7 M | 29.5 M | 31.5 M |
All numbers in USD currency
Quarterly Balance Sheet Kewaunee Scientific Corporation
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
222 K | 235 K | 247 K | 259 K | 143 K | 148 K | 198 K | 219 K | - | 228 K | 97 K | 80 K | 86 K | 91 K | - | 102 K | 108 K | - | 526 K | - | - | 97 K | 1.56 M | 822 K | 972 K | 1.26 M | 3.03 M | 1.85 M | 2.14 M | 2.43 M | 3.46 M | 3.14 M | 3.24 M | 3.35 M | 3.88 M | 3.56 M | 3.66 M | 3.77 M | 4.3 M | 3.98 M | 4.09 M | 4.19 M | 3.32 M | 4.4 M | 4.51 M | 3.27 M | 3.52 M | 3.37 M | 3.42 M | 3.42 M | - | 3.57 M | 3.62 M | 3.67 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
74.5 M | 78.6 M | 81 M | 78.3 M | 84.3 M | 80.4 M | 59.5 M | 84.1 M | 90.5 M | 82.6 M | 51.3 M | 57 M | 50 M | 47.9 M | 41.4 M | 53.3 M | 49 M | 45.2 M | 30.1 M | 45.3 M | 50.6 M | 39.5 M | 36.6 M | 31.2 M | 36.5 M | 36.9 M | 32.9 M | 40.6 M | 32.4 M | 37.7 M | 36 M | 36.8 M | 38.7 M | 33.9 M | 29.3 M | 33.7 M | 34.3 M | 34.3 M | 33.1 M | 29.7 M | 30.9 M | 28.5 M | 27.9 M | 31.7 M | 34.8 M | 35 M | 26.5 M | 33.9 M | 33.2 M | 33.2 M | - | 27.9 M | 30.8 M | 30 M |
Deferred Revenue |
4.94 M | 4.37 M | 10.2 M | 4.92 M | 7.07 M | 4.1 M | 3.1 M | 11.4 M | 14.1 M | 3.53 M | 3.64 M | 3.05 M | 2.56 M | 3.12 M | 1.8 M | 2.77 M | 1.43 M | 2.51 M | 1.45 M | 2.03 M | 1.52 M | 1.6 M | 1.96 M | 1.56 M | 1.76 M | 1.88 M | 548 K | 1.51 M | 773 K | 5.81 M | 683 K | 1.12 M | 811 K | 785 K | 296 K | 693 K | 602 K | 216 K | 171 K | 238 K | 283 K | 137 K | 939 K | 68 K | 648 K | 488 K | 850 K | 1.06 M | 1.5 M | 1.5 M | - | 1.06 M | 1.45 M | 1.11 M |
Retained Earnings |
49.7 M | 47.5 M | 36.5 M | 34 M | 31.2 M | 28.8 M | 28.4 M | 27 M | 27.3 M | 28 M | 37.1 M | 29.7 M | 32.8 M | 34.1 M | 38.9 M | 37 M | 37.2 M | 37.8 M | 45.3 M | 40.8 M | 43.5 M | 43.6 M | 42.2 M | 45.9 M | 44.3 M | 43.8 M | 38.8 M | 41.8 M | 40.5 M | 39.8 M | 35.8 M | 38.9 M | 37.8 M | 36.8 M | 34.1 M | 35.4 M | 35 M | 34.4 M | 31.4 M | 33.9 M | 33 M | 32.1 M | 30.2 M | 31.1 M | 30.6 M | 31.2 M | 28.2 M | 29.9 M | 29.6 M | 29.6 M | - | 28.6 M | 29 M | 29.2 M |
Total Assets |
132 M | 135 M | 126 M | 122 M | 125 M | 119 M | 95.7 M | 119 M | 126 M | 119 M | 89.6 M | 94.3 M | 90.3 M | 89.4 M | 84.4 M | 91.4 M | 87.2 M | 83.9 M | 79.6 M | 90.3 M | 98.5 M | 87.2 M | 82.7 M | 80.6 M | 84.9 M | 85.1 M | 73.6 M | 85.9 M | 76.6 M | 80.9 M | 72.8 M | 77.6 M | 78.4 M | 72.4 M | 65.4 M | 70.2 M | 70.1 M | 69.5 M | 65 M | 65.8 M | 66.1 M | 62.7 M | 60.6 M | 63.2 M | 65.9 M | 68.7 M | 58.4 M | 66.5 M | 65.2 M | 65.2 M | - | 60.1 M | 63.8 M | 63.1 M |
Cash and Cash Equivalents |
24.2 M | 23.3 M | 21.3 M | 13.7 M | 21.6 M | 8.08 M | 18.4 M | 16.3 M | 21.5 M | 4.43 M | 5.56 M | 5.53 M | 5.47 M | 5.21 M | 3.55 M | 5.76 M | 3.99 M | 4.36 M | 10.8 M | 7.65 M | 11.7 M | 10.6 M | 9.18 M | 9.48 M | 9.06 M | 9.72 M | 8.25 M | 11.8 M | 12 M | 12.5 M | 3.71 M | 7.58 M | 7.58 M | 6.71 M | 3.86 M | 3.27 M | 3.27 M | 2.9 M | 6.66 M | 4.86 M | 4.86 M | 4.37 M | 4.2 M | 5.28 M | 5.28 M | 4.41 M | 3.93 M | 5.88 M | 5.88 M | 7.72 M | 2.16 M | 3.21 M | 3.21 M | 2.65 M |
Book Value |
57.5 M | 56.2 M | 45.3 M | 43.4 M | 40.5 M | 38.5 M | 36.2 M | 35 M | 35.2 M | 36.2 M | 38.3 M | 37.3 M | 40.3 M | 41.5 M | 42.9 M | 38.1 M | 38.2 M | 38.7 M | 49.5 M | 45 M | 47.9 M | 47.7 M | 46.1 M | 49.4 M | 48.4 M | 48.2 M | 40.7 M | 45.3 M | 44.2 M | 43.3 M | 36.8 M | 40.7 M | 39.7 M | 38.6 M | 36.2 M | 36.5 M | 35.8 M | 35.2 M | 31.9 M | 36.1 M | 35.3 M | 34.2 M | 32.7 M | 31.6 M | 31 M | 33.7 M | 31.9 M | 32.6 M | 32 M | 32 M | - | 32.2 M | 32.9 M | 33 M |
Total Shareholders Equity |
56 M | 54.8 M | 44.1 M | 42.1 M | 39.4 M | 37.4 M | 35.4 M | 34.4 M | 34.7 M | 35.7 M | 38.1 M | 37 M | 40.1 M | 40.1 M | 42.6 M | 37.8 M | 37.8 M | 37.9 M | 49 M | 44.5 M | 44.5 M | 47.3 M | 46.3 M | 48.9 M | 48.7 M | 47.9 M | 40.3 M | 45.5 M | 44.9 M | 43.8 M | 36.5 M | 40.4 M | 39.3 M | 38.2 M | 35.9 M | 36.2 M | 35.5 M | 34.9 M | 31.6 M | 35.8 M | 35 M | 34 M | 30.9 M | 31.4 M | 30.8 M | 31.7 M | 30.2 M | 30.4 M | 29.8 M | 29.8 M | - | 30.7 M | 31.3 M | 31.5 M |
All numbers in USD currency